Wanjia Group Holdings Limited (HKG:0401)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.1050
-0.0010 (-0.94%)
At close: Mar 6, 2026

Revenue by Segment

Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17 Mar '16
Pharmaceutical Wholesale and Distribution Business
50.49M51.54M52.28M51.18M58.77M
Pharmaceutical Wholesale and Distribution Business Growth
-2.03%-1.42%2.14%-12.91%-15.47%
Hemodialysis Treatment and Consultancy Service Business
111.20M129.56M121.42M103.64M55.32M
Hemodialysis Treatment and Consultancy Service Business Growth
-14.17%6.70%17.16%87.36%101.48%
Total
161.69M181.09M173.70M154.82M114.09M
Total Growth
-10.71%4.25%12.19%35.71%17.64%

Revenue by Geography

Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17 Mar '16
People's Republic of China (PRC)
161.69M181.09M173.70M154.82M114.09M
People's Republic of China (PRC) Growth
-10.71%4.25%12.19%35.71%17.64%
Total
161.69M181.09M173.70M154.82M114.09M
Total Growth
-10.71%4.25%12.19%35.71%17.64%
Source: S&P Global Market Intelligence.